Literature DB >> 16497872

Molecular characterisation of pancreatic ductal adenocarcinoma in patients under 40.

F Bergmann1, S Aulmann, M N Wente, R Penzel, I Esposito, J Kleeff, H Friess, P Schirmacher.   

Abstract

BACKGROUND: Pancreatic ductal adenocarcinoma (PDAC) rarely affects people under 40.
OBJECTIVES: To determine whether the clinical, pathomorphological and genetic features of PDAC occurring in young patients (<or=40 years) differ from those in elderly patients.
METHODS: Clinical and pathomorphological data were obtained from seven patients presenting with PDAC, with age ranging from 35 to 40 years of age (mean 38 years). All tumours were characterised by using immunohistochemistry and molecular genetics.
RESULTS: All seven patients were women and lacked an association to cancer-predisposing genetic syndromes. Four patients were smokers and one had non-hereditary chronic pancreatitis. Pathomorphologically, tumours in three patients displayed moderate differentiation and four showed poor differentiation including one adenosquamous carcinoma. All tumours showed overexpression of transforming growth factor beta1 and loss or significant reduction of Smad4. Accumulation of p53 and overexpression of epidermal growth factor receptor (EGFR) were seen in five and four patients, respectively. No expression of p16, oestrogen hormone receptor or progesterone receptor was found. Mismatch repair gene products (MutL homologue 1 (MLH1), MSH2 and MSH6) were expressed in all tumours. Mutational analyses showed K-ras mutations in only three of the seven tumours.
CONCLUSION: A large clinical, pathomorphological and genetic overlap of PDAC in young patients aged under 40 is seen with that in elderly patients. The existence of yet undefined initiating events of pancreatic carcinogenesis is suggested by the low rate of K-ras mutations, in at least a subgroup of young patients.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16497872      PMCID: PMC1860388          DOI: 10.1136/jcp.2005.027292

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  35 in total

Review 1.  The Raf/MEK/ERK pathway: new concepts of activation.

Authors:  C Peyssonnaux; A Eychène
Journal:  Biol Cell       Date:  2001-09       Impact factor: 4.458

2.  Fanconi anemia gene mutations in young-onset pancreatic cancer.

Authors:  Michiel S van der Heijden; Charles J Yeo; Ralph H Hruban; Scott E Kern
Journal:  Cancer Res       Date:  2003-05-15       Impact factor: 12.701

3.  The SMAD4 protein and prognosis of pancreatic ductal adenocarcinoma.

Authors:  M Tascilar; H G Skinner; C Rosty; T Sohn; R E Wilentz; G J Offerhaus; V Adsay; R A Abrams; J L Cameron; S E Kern; C J Yeo; R H Hruban; M Goggins
Journal:  Clin Cancer Res       Date:  2001-12       Impact factor: 12.531

Review 4.  Epidemiology of pancreatic cancer: an overview.

Authors:  P Ghadirian; H T Lynch; D Krewski
Journal:  Cancer Detect Prev       Date:  2003

5.  Pancreatic cancer in father and son.

Authors:  R R Reimer; J F Fraumeni; R F Ozols; R Bender
Journal:  Lancet       Date:  1977-04-23       Impact factor: 79.321

6.  Increased risk of incident pancreatic cancer among first-degree relatives of patients with familial pancreatic cancer.

Authors:  A C Tersmette; G M Petersen; G J Offerhaus; F C Falatko; K A Brune; M Goggins; E Rozenblum; R E Wilentz; C J Yeo; J L Cameron; S E Kern; R H Hruban
Journal:  Clin Cancer Res       Date:  2001-03       Impact factor: 12.531

7.  DPC4/Smad4 expression and outcome in pancreatic ductal adenocarcinoma.

Authors:  Andrew V Biankin; Adrienne L Morey; C-Soon Lee; James G Kench; Sandra A Biankin; Henry C Hook; Darren R Head; Thomas B Hugh; Robert L Sutherland; Susan M Henshall
Journal:  J Clin Oncol       Date:  2002-12-01       Impact factor: 44.544

8.  Allelic loss is often the first hit in the biallelic inactivation of the p53 and DPC4 genes during pancreatic carcinogenesis.

Authors:  J Lüttges; H Galehdari; V Bröcker; I Schwarte-Waldhoff; D Henne-Bruns; G Klöppel; W Schmiegel; S A Hahn
Journal:  Am J Pathol       Date:  2001-05       Impact factor: 4.307

9.  Loss of expression of Dpc4 in pancreatic intraepithelial neoplasia: evidence that DPC4 inactivation occurs late in neoplastic progression.

Authors:  R E Wilentz; C A Iacobuzio-Donahue; P Argani; D M McCarthy; J L Parsons; C J Yeo; S E Kern; R H Hruban
Journal:  Cancer Res       Date:  2000-04-01       Impact factor: 12.701

10.  Mutations of the BRAF gene in human cancer.

Authors:  Helen Davies; Graham R Bignell; Charles Cox; Philip Stephens; Sarah Edkins; Sheila Clegg; Jon Teague; Hayley Woffendin; Mathew J Garnett; William Bottomley; Neil Davis; Ed Dicks; Rebecca Ewing; Yvonne Floyd; Kristian Gray; Sarah Hall; Rachel Hawes; Jaime Hughes; Vivian Kosmidou; Andrew Menzies; Catherine Mould; Adrian Parker; Claire Stevens; Stephen Watt; Steven Hooper; Rebecca Wilson; Hiran Jayatilake; Barry A Gusterson; Colin Cooper; Janet Shipley; Darren Hargrave; Katherine Pritchard-Jones; Norman Maitland; Georgia Chenevix-Trench; Gregory J Riggins; Darell D Bigner; Giuseppe Palmieri; Antonio Cossu; Adrienne Flanagan; Andrew Nicholson; Judy W C Ho; Suet Y Leung; Siu T Yuen; Barbara L Weber; Hilliard F Seigler; Timothy L Darrow; Hugh Paterson; Richard Marais; Christopher J Marshall; Richard Wooster; Michael R Stratton; P Andrew Futreal
Journal:  Nature       Date:  2002-06-09       Impact factor: 49.962

View more
  18 in total

1.  The Catalogue of Somatic Mutations in Cancer (COSMIC).

Authors:  S A Forbes; G Bhamra; S Bamford; E Dawson; C Kok; J Clements; A Menzies; J W Teague; P A Futreal; M R Stratton
Journal:  Curr Protoc Hum Genet       Date:  2008-04

2.  Undifferentiated Carcinoma With Osteoclastic Giant Cells of the Pancreas: Clinicopathologic Analysis of 38 Cases Highlights a More Protracted Clinical Course Than Currently Appreciated.

Authors:  Takashi Muraki; Michelle D Reid; Olca Basturk; Kee-Taek Jang; Gabriela Bedolla; Pelin Bagci; Pardeep Mittal; Bahar Memis; Nora Katabi; Sudeshna Bandyopadhyay; Juan M Sarmiento; Alyssa Krasinskas; David S Klimstra; Volkan Adsay
Journal:  Am J Surg Pathol       Date:  2016-09       Impact factor: 6.394

3.  Poorly differentiated ductal adenocarcinoma of the pancreas with rapid progression in a young man.

Authors:  Koji Tezuka; Tomoharu Ishiyama; Akiko Takeshita; Hidekazu Matsumoto; Akira Jingu; Jiro Kikuchi; Hideyuki Yamaya; Rintaro Ohe; Tetsuya Ishizawa
Journal:  Clin J Gastroenterol       Date:  2018-04-16

4.  Acinar cell carcinomas of the pancreas: a molecular analysis in a series of 57 cases.

Authors:  Frank Bergmann; Sebastian Aulmann; Bence Sipos; Matthias Kloor; Anja von Heydebreck; Johannes Schweipert; Andreas Harjung; Philipp Mayer; Werner Hartwig; Gerhard Moldenhauer; David Capper; Gerhard Dyckhoff; Kolja Freier; Esther Herpel; Anja Schleider; Peter Schirmacher; Gunhild Mechtersheimer; Günter Klöppel; Hendrik Bläker
Journal:  Virchows Arch       Date:  2014-10-09       Impact factor: 4.064

5.  Genomic Landscape of Pancreatic Adenocarcinoma in Younger versus Older Patients: Does Age Matter?

Authors:  Irit Ben-Aharon; Moshe Elkabets; Raphael Pelossof; Kenneth H Yu; Christine A Iacubuzio-Donahue; Steven D Leach; Maeve A Lowery; Karyn A Goodman; Eileen M O'Reilly
Journal:  Clin Cancer Res       Date:  2019-01-07       Impact factor: 12.531

6.  Pancreatic adenocarcinoma in young adults in a moroccan population.

Authors:  S Raissouni; G Rais; H Mrabti; F Raissouni; H Mouzount; M Aitelhaj; S El Khoyaali; A Mohtaram; H Errihani
Journal:  J Gastrointest Cancer       Date:  2012-12

Review 7.  [Pancreatic acinar neoplasms : Comparative molecular characterization].

Authors:  F Bergmann
Journal:  Pathologe       Date:  2016-11       Impact factor: 1.011

8.  MLH1 as a direct target of MiR-155 and a potential predictor of favorable prognosis in pancreatic cancer.

Authors:  Wen-Jing Liu; Yu-Pei Zhao; Tai-Ping Zhang; Li Zhou; Quan-Cai Cui; Wei-Xun Zhou; Lei You; Ge Chen; Hong Shu
Journal:  J Gastrointest Surg       Date:  2013-05-29       Impact factor: 3.452

9.  Young patients undergoing resection of pancreatic cancer fare better than their older counterparts.

Authors:  Jin He; Barish H Edil; John L Cameron; Richard D Schulick; Ralph H Hruban; Joseph M Herman; Lei Zheng; Christine Iacobuzio-Donahue; Nita Ahuja; Timothy M Pawlik; Christopher L Wolfgang
Journal:  J Gastrointest Surg       Date:  2012-11-27       Impact factor: 3.452

10.  Growth factor mediated signaling in pancreatic pathogenesis.

Authors:  Debashis Nandy; Debabrata Mukhopadhyay
Journal:  Cancers (Basel)       Date:  2011-02-24       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.